Clinical Trial Update: FUDR/Oxaliplatin HAI Plus Irinotecan vs. FOLFOXIRI Chemotherapy in Treating Initially Unresectable CRCLM [Phase 3]

View source ↗

Summary

Phase 3 trial comparing FUDR/Oxaliplatin hepatic arterial infusion plus Irinotecan versus FOLFOXIRI chemotherapy in initially unresectable colorectal cancer wit…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colorectal Cancer
• Liver Metastases

Drugs mentioned

• FOLFOXIRI chemotherapy (FOLFOXIRI)
• FUDR/Oxaliplatin hepatic arterial infusion (FUDR + oxaliplatin hepatic arterial infusion)
• Irinotecan (Irinotecan)

Snippet

Sponsor: Sun Yat-sen University | Conditions: Metastatic Colorectal Cancer, Liver Metastases | Phase 3 | Status: TERMINATED